PAVmed Announces Quarterly Conference Call and Webcast to Be Held on August 17, 2016

PAVmed Inc. (Nasdaq:PAVM), a highly differentiated, multi-product medical device company, today announced that the Company will host a conference call on August 17, 2016 at 4:30 p.m. Eastern time during which PAVmed’s Chairman and CEO, Dr. Lishan Aklog, will provide a business update and discuss near term milestones and growth strategy.

To access the conference call, U.S.-based listeners should dial [phone] and international listeners should dial [phone]. All listeners should provide the following passcode: 65791790. Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company’s website at www.pavm.com.

Following the conclusion of the conference call, a replay will be available through August 24, 2016 and can be accessed by dialing [phone] from within the U.S. or [phone] from outside the U.S. All listeners should provide passcode 9950. The webcast will be available for 90 days.

About PAVmed

PAVmed Inc. (Nasdaq:PAVM) is a highly differentiated, multi-product medical device company employing a unique business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding multi-product pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs, have attractive regulatory pathways and market opportunities and encompass a broad spectrum of clinical areas including carpal tunnel syndrome (CarpX™), medical infusions (NextFlo™ and NextCath™), interventional radiology (PortIO™ and NextCath), tissue ablation and cardiovascular intervention (Caldus™). The Company intends to further expand its pipeline through engagements with clinician innovators and leading academic medical centers. For further information, please visit www.pavm.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160812005603/en/

For PAVmed Inc.InvestorsLHAKim Sutton Golodetz, [e-mail] Sandoval, [e-mail]